Additionally, EGF stimulation promotes SHCBP1 nuclear localization, where it interacts with CBP to facilitate β-catenin acetylation, thereby activating stem cell markers including CD44 and EpCAM in NSCLC [21]. The gene discussed is SHCBP1; the disease is non-small cell lung carcinoma.